Literature DB >> 26779647

[Surgical approach of gastroduodenal neuroendocrine neoplasms].

V Fendrich1, D K Bartsch2.   

Abstract

Gastroduodenal neuroendocrine tumors are rare but an increase in incidence has been recognized worldwide over the past 35 years. At the same time the prognosis of patients has substantially improved because the majority of these tumors can now be detected at an early stage. Neuroendocrine neoplasms (NENs) of the stomach are the most frequent neoplasms of neuroendocrine origin in the gastrointestinal tract. The therapeutic management of these tumors is complicated by the fact that they must be classified not only by staging and grading but also according to their pathophysiological background (types). These types differ in biological behavior and therefore have an influence on the therapeutic concept. Because more than 90 % of duodenal NENs are often asymptomatic and are as a rule identified at a curable stage, resection of the tumor should always be the first line of therapy. The therapeutic strategies vary from local endoscopic resection (duodenotomy with excision) up to pancreas retaining duodenectomy and pylorus retaining or classical Whipple procedures. This article presents the various surgical approaches to gastric and duodenal NENs.

Entities:  

Keywords:  Gastrointestinal tract; Interdisciplinary management; Neoplasms; Neuroendocrine tumors; Surgical procedures

Mesh:

Year:  2016        PMID: 26779647     DOI: 10.1007/s00104-015-0138-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  31 in total

1.  Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.

Authors:  William C Chen; Richard R P Warner; Stephen C Ward; Noam Harpaz; Celia M Divino; Steven H Itzkowitz; Michelle K Kim
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Well-differentiated gastric tumors/carcinomas.

Authors:  Philippe Ruszniewski; Gianfranco Delle Fave; Guillaume Cadiot; Paul Komminoth; Daniel Chung; Beata Kos-Kudla; Reza Kianmanesh; David Hochhauser; Rudolf Arnold; Hakan Ahlman; Stanislas Pauwels; Dik J Kwekkeboom; Guido Rindi
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

3.  Carcinoid tumors of the duodenum.

Authors:  John T Mullen; Huamin Wang; James C Yao; Jeffrey H Lee; Nancy D Perrier; Peter W T Pisters; Jeffrey E Lee; Douglas B Evans
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

Review 4.  Endocrine tumours of the stomach.

Authors:  Gianfranco Delle Fave; Gabriele Capurso; Massimo Milione; Francesco Panzuto
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

5.  Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.

Authors:  Jeffrey A Norton; Marc L Melcher; Fathia Gibril; Robert T Jensen
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

6.  Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors.

Authors:  Junko Ozao-Choy; Kerri Buch; James A Strauchen; Richard R P Warner; Celia M Divino
Journal:  J Surg Res       Date:  2010-02-04       Impact factor: 2.192

7.  [Neuroendocrine tumors of the stomach. Risk stratification and therapy].

Authors:  G Klöppel; H Scherübl
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

8.  Minimally invasive surgery for resection of duodenal carcinoid tumors: endoscopic full-thickness resection under laparoscopic observation.

Authors:  Hironori Tsujimoto; Takashi Ichikura; Shigeaki Nagao; Tomoki Sato; Satoshi Ono; Satoshi Aiko; Shuichi Hiraki; Yoshihisa Yaguchi; Naoko Sakamoto; Takemaru Tanimizu; Junji Yamamoto; Kazuo Hase
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

9.  Defining surgical indications for type I gastric carcinoid tumor.

Authors:  Rebecca A Gladdy; Vivian E Strong; Daniel Coit; Peter J Allen; Hans Gerdes; Jinru Shia; David S Klimstra; Murray F Brennan; Laura H Tang
Journal:  Ann Surg Oncol       Date:  2009-11       Impact factor: 5.344

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  1 in total

Review 1.  [Early endocrine neoplasia of the pancreas].

Authors:  V Fendrich; D K Bartsch
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.